MedTrace Logo

IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation

NCT06157164 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2025-04-04

No results posted yet for this study

Summary

To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

OTHER

UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP)

Simultaneous UroLift™ and Holmium Laser Enucleation of the Prostate (HoLEP) for the Treatment of BPH in Men with Prominent Median Lobe Desiring Preservation of Ejaculation

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Donald Neff · University of Kansas Medical Center

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-06
Primary Completion
2025-01-14
Completion
2025-01-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06157164 on ClinicalTrials.gov